Legal Representation
Attorney
Kimberly B. Herman
USPTO Deadlines
Next Deadline
18 days remaining
Published for Opposition
Due Date
January 08, 2026
Extension Available
Until February 08, 2026
Application History
15 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 9, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 9, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 3, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 7, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 4, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 4, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 4, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 21, 2025 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Aug 21, 2025 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| May 21, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 21, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 21, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 13, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 26, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 18, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Diagnostic preparations and materials being diagnostic agents and substances for medical purposes; biochemical preparations for the treatment of cancer; biological preparations for the treatment of cancer; chemical preparations for the treatment of cancer; chemical preparations for veterinary purposes, specifically for the treatment of cancer; nucleic acid sequences for medical and veterinary purposes; reagents for use in medical genetic testing; reagents for use in veterinary genetic testing; reagents for medical use
Class 042
Analytical medical research laboratory services; blood analysis services for scientific research purposes; consultancy in the field of scientific research; contract research services relating to molecular sciences; design and development of medical technology being diagnostic tests and cancer monitoring tests; laboratory services namely DNA testing services to determine paternity; genetic scientific research; research laboratory analysis services in the field of bacteriology; laboratory research in the field of gene expression; medical research laboratories; laboratory services for analytical testing of biological material such as DNA and RNA; laboratory testing of materials in the field of genetics and genetic engineering; provision of information relating to scientific research; research and development in the field of biotechnology; research laboratory analysis services in the pharmaceutical and biotechnology fields; scientific laboratory services; scientific research; scientific research and analysis in the field of genetics and genetic engineering; scientific research for medical purposes; scientific research conducted using databases; scientific services, namely scientific laboratory services; scientific testing services in the field of genetics and genetic engineering; medical and pharmacological research services
Class 044
Human healthcare services in the field of oncology testing and detection and treatment of molecular residual disease; medical services in the field of oncology testing and detection and treatment of molecular residual disease; genetic counseling; genetic testing of animals for diagnostic or treatment purposes; health care services offered through a network of health care providers on a contract basis in the field of oncology testing and detection and treatment of molecular residual disease; cancer screening services; laboratory analysis services relating to the treatment of persons provided by medical laboratories; medical and healthcare clinics in the field of oncology testing and detection and treatment of molecular residual disease; medical and healthcare services in the field of oncology testing and detection and treatment of molecular residual disease; medical services, namely monitoring of patients; pathology services, namely, analysis services, diagnostic services and monitoring services for studying diseases; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; blood analysis services being medical analysis services for diagnostic treatment purposes provided by medical laboratories
Classification
International Classes
005
042
044